Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04952389 · ClinicalTrials.gov registry record · NA
Acupuncture Therapy for COVID-Related Olfactory Loss
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT04952389: Completed NA study, sponsored by Mayo Clinic.
NCT04952389 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04952389, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
This study is looking at the role of acupuncture as a treatment for olfactory dysfunction in patients who tested positive for COVID-19.
Interventions
- DRUG Budesonide
- DEVICE Acupuncture Therapy
- OTHER Olfactory Training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2021-12-07 |
| Est. Completion | 2023-06-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04952389
The ClinicalTrials.gov registry entry for NCT04952389 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Budesonide is the first listed.
NCT04952389 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04952389 about?
NCT04952389 is a clinical study titled "Acupuncture Therapy for COVID-Related Olfactory Loss". This study is looking at the role of acupuncture as a treatment for olfactory dysfunction in patients who tested positive for COVID-19.
What is the current status of trial NCT04952389?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2021-12-07. Estimated completion is 2023-06-09.
What interventions are being tested in trial NCT04952389?
The interventions under investigation include: Budesonide (DRUG), Acupuncture Therapy (DEVICE), Olfactory Training (OTHER).
Who is sponsoring clinical trial NCT04952389?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.